NORPACT-1: implications for future trials - Authors' reply.

Autor: Labori KJ; Department of Hepato Pancreato Biliary Surgery, Oslo University Hospital, Oslo 0372, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: k.j.labori@medisin.uio.no., Bratlie SO; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Surgery, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Dueland S; Department of Oncology, Oslo University Hospital, Oslo, Norway., Lassen K; Department of Hepato Pancreato Biliary Surgery, Oslo University Hospital, Oslo 0372, Norway; Institute of Clinical Medicine, the Arctic University of Norway, Tromsø, Norway.
Jazyk: angličtina
Zdroj: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 May; Vol. 9 (5), pp. 408-409.
DOI: 10.1016/S2468-1253(24)00079-7
Abstrakt: Competing Interests: We declare no competing interests.
Databáze: MEDLINE